Alpha Teknova (TKNO) Capital Expenditures Growth (1y) (2021 - 2026)
Alpha Teknova (TKNO) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -21.54% |
| 10 | Alpha Teknova | 258.38 Mn | 240.60 Mn | 3.78 Mn | 7.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.28% |
| Dec 31, 2025 | -38.62% |
| Sep 30, 2025 | 16.92% |
| Jun 30, 2025 | 80.00% |
| Mar 31, 2025 | 83.93% |
| Dec 31, 2024 | 81.73% |
| Sep 30, 2024 | -65.95% |
| Jun 30, 2024 | -95.08% |
| Mar 31, 2024 | -97.40% |
| Dec 31, 2023 | -93.40% |
| Sep 30, 2023 | -85.23% |
| Jun 30, 2023 | -78.59% |
| Mar 31, 2023 | -27.13% |
| Dec 31, 2022 | -36.18% |
| Sep 30, 2022 | 68.47% |
| Jun 30, 2022 | 133.63% |
| Mar 31, 2022 | 52.34% |
| Dec 31, 2021 | 111.95% |
| Sep 30, 2021 | 284.55% |